SC
Steven Cohen (Point72) disclosed increased in NAUTILUS BIOTECHNOLOGY INC
Steven Cohen (Point72) filed a 13F change in NAUTILUS BIOTECHNOLOGY INC (63909J108) on 2026-05-15, covering period end 2026-03-31.
Action
Increased
Capital
$203,583 reported value
Institutional 13F Signals1 evidence source
Why it matters
This signal is anchored to the SEC filing date while retaining the underlying 13F period end.